François Anger
Chairman
Haematology
ADDMEDICA
Hungary
Biography
François Anger is a president and owner of addmedica
Research Interest
In hematology, the company holds the European Marketing Approval of the sole drug indicated in a rare disease called Sickle Cell Disease. In the domain of organ grafts, it distributed in France the best fitted preservation solution for pulmonary grafts, as well as an experimental solution designed to assess the functionality of the lung before transplantation. Lastly, in the domain of wound healing, it commercializes a range of high technology products, mainly for hospital use.
